Faz 3 Jijman AMP-061 Terapi jèn pou Hemofil B depase medikaman sib la

Faz 3 Jijman AMP-061 Terapi jèn pou Hemofil B depase medikaman sib la

Emofili Nouvèl Jodi a

Imaj

Please enable the javascript to submit this form

Sipòte pa sibvansyon edikasyonèl nan Bayer, BioMarin, Freeline Therapeutics Limited, Pfizer Inc., Shire, Spark Therapeutics, ak uniQure, Inc.

Esansyèl SSL